Probiotics for preventing ventilator‐associated pneumonia
L Bo, J Li, T Tao, Y Bai, X Ye… - Cochrane database …, 2014 - cochranelibrary.com
L Bo, J Li, T Tao, Y Bai, X Ye, RS Hotchkiss, MH Kollef, NH Crooks, X Deng
Cochrane database of systematic reviews, 2014•cochranelibrary.comBackground Ventilator‐associated pneumonia (VAP) is common in intensive care units
(ICUs). Some evidence indicates that probiotics may reduce the incidence of VAP. Several
additional published studies have demonstrated that probiotics are safe and efficacious in
preventing VAP in ICUs. We aimed to systematically summarise the results of all available
data to generate the best evidence for the prevention of VAP. Objectives
(ICUs). Some evidence indicates that probiotics may reduce the incidence of VAP. Several
additional published studies have demonstrated that probiotics are safe and efficacious in
preventing VAP in ICUs. We aimed to systematically summarise the results of all available
data to generate the best evidence for the prevention of VAP. Objectives
Background
Ventilator‐associated pneumonia (VAP) is common in intensive care units (ICUs). Some evidence indicates that probiotics may reduce the incidence of VAP. Several additional published studies have demonstrated that probiotics are safe and efficacious in preventing VAP in ICUs. We aimed to systematically summarise the results of all available data to generate the best evidence for the prevention of VAP.
Objectives
cochranelibrary.com
